{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:47Z","timestamp":1786118867201,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>\n                    This case report presents a 42-year-old woman with metastatic breast cancer refractory to multiple conventional treatments, including surgery, chemotherapy, radiotherapy, hormonal therapy, and bilateral oophorectomy. As a salvage, she received\n                    <jats:sup>177<\/jats:sup>\n                    Lu-FAPI-2286 radioligand therapy. After the first cycle, an unexpected serum \u03b2-hCG elevation was observed\u2014unusual given her history of total hysterectomy and bilateral salpingo-oophorectomy. Three hypotheses were proposed: assay interference (heterophile antibodies), emergence of second neoplasm secreting \u03b2-hCG, and tumor dedifferentiation with ectopic \u03b2-hCG expression. Unfortunately, rapid clinical progression precluded further evaluation. This case underscores the importance of awareness regarding tumor dedifferentiation and biomarker changes during novel theranostic treatments with\n                    <jats:sup>177<\/jats:sup>\n                    Lu-FAPI, emphasizing the need for vigilant multidisciplinary monitoring.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006285","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:00:18Z","timestamp":1767207618000},"page":"e642-e644","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["177Lu-FAPI-2286 Therapy in Metastatic Breast Cancer"],"prefix":"10.1097","volume":"51","author":[{"given":"Nasrin","family":"Raeisi","sequence":"first","affiliation":[{"name":"Nuclear Medicine Research Center"},{"name":"Student Research Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Saber Tanha","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center"},{"name":"Student Research Committee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamran","family":"Aryana","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Homaee Shandiz","sequence":"additional","affiliation":[{"name":"Cancer Research Center, Mashhad University of Medical Sciences (MUMS), Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3507-2077","authenticated-orcid":false,"given":"Somaye","family":"Barashki","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"R1-20260702","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1097\/RLU.0000000000005617","article-title":"FAP-targeted SPECT\/CT and PET\/CT imaging for breast cancer patients","volume":"50","author":"McGale","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R2-20260702","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/cancers15030908","article-title":"PET\/CT with fibroblast activation protein inhibitors in breast cancer: diagnostic and theranostic application\u2014a literature review","volume":"15","author":"Taralli","year":"2023","journal-title":"Cancers (Basel)"},{"key":"R3-20260702","doi-asserted-by":"crossref","first-page":"e564","DOI":"10.1097\/RLU.0000000000005753","article-title":"Favorable palliative effect of 177Lu-FAPI-2286 in two breast cancer patients with refractory bone pains","volume":"50","author":"Raeisi","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R4-20260702","doi-asserted-by":"crossref","first-page":"e410","DOI":"10.1097\/RLU.0000000000003678","article-title":"Theranostic approach in breast cancer","volume":"46","author":"Jokar","year":"2021","journal-title":"Clin Nucl Med"},{"key":"R5-20260702","doi-asserted-by":"crossref","first-page":"1236565","DOI":"10.3389\/fnume.2023.1236565","article-title":"Theranostics in breast cancer","volume":"3","author":"Vorster","year":"2023","journal-title":"Front Nucl Med"},{"key":"R6-20260702","first-page":"186","article-title":"An unusual cause of elevated serum total \u03b2hCG","volume":"37","author":"Buckner","year":"2007","journal-title":"Ann Clin Lab Sci"},{"key":"R7-20260702","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1373\/jalm.2017.022988","article-title":"False-positive pregnancy result in a patient with bone mass","volume":"2","author":"Xu","year":"2017","journal-title":"J Appl Lab Med"},{"key":"R9-20260702","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1515\/BC.2009.050","article-title":"Retrodifferentiation\u2014a mechanism for cellular regeneration?","volume":"390","author":"Hass","year":"2009","journal-title":"Biol Chem"},{"key":"R10-20260702","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/ijms18071587","article-title":"Human chorionic gonadotropin and breast cancer","volume":"18","author":"Sch\u00fcler-Toprak","year":"2017","journal-title":"Int J Mol Sci"},{"key":"R11-20260702","doi-asserted-by":"crossref","first-page":"13208","DOI":"10.1038\/s41598-023-40056-1","article-title":"Association of serum beta hCG levels in women with palpable malignant breast lesions","volume":"13","author":"Mohammed","year":"2023","journal-title":"Sci Rep"},{"key":"R12-20260702","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/stem.1219","article-title":"Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT\/\u03b2-catenin signaling","volume":"30","author":"Debeb","year":"2012","journal-title":"Stem Cells"},{"key":"R13-20260702","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3390\/cells10020264","article-title":"Human chorionic gonadotropin-mediated induction of breast cancer cell proliferation and differentiation","volume":"10","author":"Dando","year":"2021","journal-title":"Cells"},{"key":"R14-20260702","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2967\/jnumed.124.268640","article-title":"Therapy-related myeloid neoplasms after [177 Lu]Lu-PSMA therapy in patients with metastatic castration-resistant prostate cancer: a case series","volume":"66","author":"Eifer","year":"2025","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006285","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:55:17Z","timestamp":1786035317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/RLU.0000000000006285"}},"subtitle":["A Case Study Highlighting the Potential Risk of Tumor Dedifferentiation and Hormonal Marker Elevation"],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006285","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"2025-08-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}